<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20191109045376N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-07-16</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of using activity analysis strategy when using m-CIMT</public_title>
      <acronym></acronym>
      <scientific_title>Effect of occupation-based modified constraint-induced movement therapy on participation children with cerebral palsy: A double-blind randomized controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-07-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/48925</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Other, Randomization description: A stratified randomization is performed to assign children to groups. Two categories, MACS level I and II and MACS level III, are included in the table of random numbers. Plaques are enclosed in matte numbered sealed envelopes that are stored by the therapist, Blinding description: In this study, the assessor will be blind at all stages, the assessment before the intervention, the assessment after the intervention, and the assessment at the time of follow-up, and the assessor will not know which group each child is in. Also, parents and clients will not be informed about the assignment in the groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>cerebral palsy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Based on the set goals, the child will be analyzed on the basis of OTPF motor skills items. Then, based on the child's defects based on OTPF activity analysis items, according to the interests of each child, a treatment plan in the form of play and activities of daily living is designed and graded based on the principles of motor learning by the therapist and given to parents to practice with the child. Parents will also be given the necessary training (the nature and manner of doing exercises such as shaping, hardening, and repetition) to perform interventions at home. Participants in this group will be treated at home for 4 weeks, 3 days a week and 1 hour a day by the parents according to the program prepared by the therapist, during this time the less affected upper extrimity will be restricted by the strap. Also, a less affected upper extrimity will be restricted to 5 to 6 hours apart from interventions during activities of daily living. At the end of each session, the therapist will call with each parents and asked about the time limit and activities during intervention restriction time and other restriction time and activities are done by child in non-restricted time, and based on the purpose of the study (performing M-CIMT interventions based on activity analysis), parents will be given the necessary feedback. Intervention 2: Control group: According to the child's interests, the treatment plan in the form of play and activities of daily living is designed and graded (being more difficult) based on principles of motor learning by the therapist and given to the parents to practice with the child at home. Parents will also be given the necessary training (the nature and manner of doing exercises such as shaping, hardening, and repetition) to perform interventions at home. Participants in this group will receive routine m-CIMT interventions (without activity analysis and no emphasis on defects in OTPF activity analysis items when performing this technique); The duration of the interventions will be the same as the intervention group for 4 weeks, 3 days a week and 1 hour per day. Also, less affected upper extremity will be restricted 5 to 6 hours apart from interventions during daily life activities. At the end of each session, the therapist will call with each parents and asked about the time limit and activities during intervention restriction time and other restriction time and activities are done by child in non-restricted time, and based on the purpose of the study (performing routine m-CIMT interventions without activity analysis), parents will be given the necessary feedback.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Malek Amini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Madadkaran St., Shah Nazari St., Madar Square, Mirdamad Blvd, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>0098 21 222228051</telephone>
        <email>malekamini8@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Malek Amini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Madadkaran St., Shah Nazari St., Madar Square, Mirdamad Blvd, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>0098 21 222228051</telephone>
        <email>malekamini8@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The child has been diagnosed by a neurologist with cerebral palsy
The child has levels I, II and III of the MACS scale
The child can actively extend the wrist of the affected limb by 20 degrees
The child can actively extend the fingers of the affected limb by 10 degrees
The child achieve score above 44 in PBS test
The child does not have vision problems
The child does not have a behavioral problem that can withstand the restriction
The child's IQ is above 70
The child has not received upper limb surgery and Botox injections in the past 6 months and does not intend to do so during the interventions</inclusion_criteria>
      <agemin>5 years</agemin>
      <agemax>12 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Lack of desire of family or child to continue interventions</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G80.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Spastic hemiplegic cerebral palsy</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Based on the set goals, the child will be analyzed on the basis of OTPF motor skills items. Then, based on the child's defects based on OTPF activity analysis items, according to the interests of each child, a treatment plan in the form of play and activities of daily living is designed and graded based on the principles of motor learning by the therapist and given to parents to practice with the child. Parents will also be given the necessary training (the nature and manner of doing exercises such as shaping, hardening, and repetition) to perform interventions at home. Participants in this group will be treated at home for 4 weeks, 3 days a week and 1 hour a day by the parents according to the program prepared by the therapist, during this time the less affected upper extrimity will be restricted by the strap. Also, a less affected upper extrimity will be restricted to 5 to 6 hours apart from interventions during activities of daily living. At the end of each session, the therapist will call with each parents and asked about the time limit and activities during intervention restriction time and other restriction time and activities are done by child in non-restricted time, and based on the purpose of the study (performing M-CIMT interventions based on activity analysis), parents will be given the necessary feedback.</i_keyword>
      <i_keyword>Control group: According to the child's interests, the treatment plan in the form of play and activities of daily living is designed and graded (being more difficult) based on principles of motor learning by the therapist and given to the parents to practice with the child at home. Parents will also be given the necessary training (the nature and manner of doing exercises such as shaping, hardening, and repetition) to perform interventions at home. Participants in this group will receive routine m-CIMT interventions (without activity analysis and no emphasis on defects in OTPF activity analysis items when performing this technique); The duration of the interventions will be the same as the intervention group for 4 weeks, 3 days a week and 1 hour per day. Also, less affected upper extremity will be restricted 5 to 6 hours apart from interventions during daily life activities. At the end of each session, the therapist will call with each parents and asked about the time limit and activities during intervention restriction time and other restriction time and activities are done by child in non-restricted time, and based on the purpose of the study (performing routine m-CIMT interventions without activity analysis), parents will be given the necessary feedback.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The score obtained is related to the two categories of satisfaction and performance in the canadian occupational performance measure questionnaire. Timepoint: Measure participation at the beginning of the study (before the intervention), 1 and 3 months after the start of the intervention. Method of measurement: Canadian occupational performance measure questionnaire.</prim_outcome>
      <prim_outcome>Score obtained from the amount of goal achievement by the goal attainment scaling tool. Timepoint: Measure participation at the beginning of the study (before the intervention), 1 and 3 months after the start of the intervention. Method of measurement: goal attainment scaling.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Score obtained in the ABILHAND-Kids questionnaire. Timepoint: Measure manual ability at the beginning of the study (before the intervention), 1 and 3 months after the intervention. Method of measurement: ABILHAND-Kids questionnaire.</sec_outcome>
      <sec_outcome>Score obtained in the pediatric motor activity log questionnaire. Timepoint: Measure manual ability at the beginning of the study (before the intervention), 1 and 3 months after the intervention. Method of measurement: pediatric motor activity log questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-04-15</approval_date>
        <contact_name>Ethics committee of IranUniversity of Medical Sciences</contact_name>
        <contact_address>No. 39, Unit 5, Asadi Alley, between Jeyhun and Zanjan, Toos St. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
